Insight
Hospitals & Medical TourismCompanies & operators

Bangkok Chain Hospital

Bangkok Chain Hospital (SET: BCH) operates the Kasemrad hospital chain — 15+ hospitals across the Bangkok metropolitan area and selected provincial locations. FY2024 revenue in the THB 15B range. The franchise is built around SSS, UCS contract volume, with a higher share of public-insurance-funded beds than any listed peer. COVID-era PCR-testing revenue has normalised; forward economics revert to contract-reimbursement dynamics under SSO's capitation-rate decisions.

Snapshot

Headline numbers a buyer checks first.

FY2024 revenue

~THB 15B

FY2024

Hospital count

15+

FY2024

Brand

Kasemrad

FY2024

Payor mix

SSS, UCS contract-heavy

FY2024

Listing

SET: BCH

2014

What this company actually does

BCH operates the Kasemrad hospital chain — 15+ general, secondary-care hospitals across Bangkok, Nonthaburi, Ratchaburi, Chachoengsao, and Sra Kaeo. The franchise serves mid-market Thai patients with heavy SSS, UCS contract volume. Individual hospitals target specific catchment areas with primary, secondary care; higher-acuity cases are referred in-network or externally. This model produces stable volume but modest margins — the mid-market bet rather than the premium or medical-tourism plays that BDMS, BH occupy.[]

The strategic question for 2026-2028 is diversification. BCH has been adding cash-pay, specialty services (dialysis, imaging, wellness) to reduce dependence on SSS, UCS reimbursement rates. The forward thesis is whether this diversification gathers enough scale to insulate earnings from capitation-rate decisions — or whether BCH remains structurally tethered to SSO, NHSO pricing.[]

Bangkok Chain Hospital FY2024 Form 56-1
Data as of: FY2024

Business segments

Core network

Kasemrad hospital chain — 15+ hospitals

General, secondary-care hospitals across Bangkok (Lak Si, Nonthaburi), Ratchaburi, Chachoengsao, Sra Kaeo. Mid-market catchment model; 2,300+ licensed beds. Revenue ~ $434.8M FY2024; volume-driven on SSS, UCS contracts.

Payor mix

SSS, UCS contract revenue — dominant

Highest SSS, UCS contract share among listed peers. ~7.7% of all SSO private-hospital patient volume. Capitation rate stability is the binding earnings variable; rebasing directly flows through margins without offset.

Diversification

Specialty services, dialysis, imaging

Ongoing expansion of cash-pay, specialty services — dialysis centres, imaging, wellness — to reduce SSS, UCS dependency. Strategic question for 2026-2028 is whether diversification scale insulates earnings from capitation-rate decisions.

Brand tiers

Multi-brand — World Medical, Kasemrad International

BCH operates multiple hospital tiers: World Medical Centre, Kasemrad International, Kasemrad, Karunvej. Brand stratification allows broader payor-mix targeting without cannibalising core SSS contract patient flow.

Watchpoints for the next annual report

SSS capitation rate moves

Any rebasing up/down directly flows through BCH margins.

Cash-pay revenue share

Diversification progress; proportion of non-contract revenue.

Hospital-count expansion

New Kasemrad openings signal scale, catchment investment.

PCR-testing cohort revenue

COVID-era revenue has normalised; watch for replacement diagnostics.

Thai listed hospital groups — mid-market segment comparison

BDMS

Listing

SET: BDMS

FY2024 revenue

~ $2.32B+

Hospital count

50+

Payor mix

Cash-pay, private insurance dominant

Bangkok Chain Hospital (BCH)

Listing

SET: BCH

FY2024 revenue

~ $434.8M

Hospital count

15+

Payor mix

SSS, UCS contract-heavy

Chularat Hospital

Listing

SET: CHG

FY2024 revenue

~ $202.9M

Hospital count

~10

Payor mix

SSS, corporate (EEC workers)

Praram 9 Hospital

Listing

SET: PR9

FY2024 revenue

~ $0.116-5B

Hospital count

1 flagship

Payor mix

Cash-pay specialty tertiary

SET 56-1 filings FY2024NHSO SSO annual reports
Data as of: FY2024

Related Market profiles

Peers, parents, partners, agencies, and other Hospitals & Medical Tourism actors.

Competitor

Bangkok Dusit Medical Services

Larger peer with broader brand stratification.

Open Market profile →

Competitor

Chularat Hospital

Eastern Thailand industrial-estate specialist.

Open Market profile →

Sector peer

Asian Cosmetic Surgery Center

Bangkok cosmetic surgery center serving domestic and international patients.

Open Market profile →

Sector peer

Bangkok Hospital

BDMS flagship hospital brand serving Thai and international patients.

Open Market profile →

Sources + data provenance

Every filing, filing-adjacent register, or trusted industry source cited in this profile.

Bangkok Chain Hospital (SET: BCH) FY2024 Form 56-1 One Report

Grade

Primary

As of

2025-03-15

Auto-generated from the company source registry.
Primary filings are the first choice. Trusted industry research (Fitch, S&P, Moody's, Opensignal, GSMA, Omdia, JLL, Knight Frank, CBRE, Colliers, STR, etc.) is used for triangulation per SOP — never as the sole anchor.

Reports featuring this profile

Thailand Senior Long-Stay & Retirement Visa 2027 Market Intelligence

Mid-tier private chain; foreign-payer growth on chronic-disease management

Open report →

Sits alongside 6 other Atlas profiles

Thailand Hospital REIT & Asset-Light Healthcare 2027 Market Intelligence

Mid-tier multi-site chain with SSO mix, most asset-heavy chain relative to revenue

Open report →

Sits alongside 4 other Atlas profiles

Thailand Medical Tourism 2027: The Corridor Thesis

Mid-market network, regional reach, growing international cohort

Open report →

Sits alongside 4 other Atlas profiles

The Thai Private Hospital Tier Map: BDMS Empire, Bumrungrad Premium, and Bangkok Hospital Network

Mid-market multi-province operator.

Open report →

Sits alongside 4 other Atlas profiles

Thai Medical Tourism: Acuity Mix and the International-Cohort Recovery

Mid-market network, regional reach

Open report →

Sits alongside 2 other Atlas profiles

Bangkok Dusit Medical Services (BDMS): Private Hospital Network Economics

Mid-market listed group (SET: BCH); 16 hospitals, 2 polyclinics, 2,323 licensed beds; c.7.7% SSO private-hospital patient share; roughly one-third of FY2024 revenue (THB 11.83B) from SSO contracts; st

Open report →

Sits alongside 2 other Atlas profiles

BCH Bangkok Chain Hospital: Mid-Market Positioning and IPO Aftermath

Mid-market listed group (SET: BCH); 16 hospitals, 2 polyclinics, 2,323 licensed beds across four brand tiers (World Medical, Kasemrad International, Kasemrad, Karunvej); c.7.7% SSO private-hospital pa

Open report →

Sits alongside 2 other Atlas profiles

Thailand Healthcare Services & Medical Tourism Market Intelligence

Mid-market Kasemrad operator; SSS, UCS contract-heavy; THB 15B FY2024.

Open report →

Sits alongside 7 other Atlas profiles

Thailand Digital Health & Telemedicine Market Intelligence

BCH digital health, telemedicine services.

Open report →

Sits alongside 4 other Atlas profiles

Thailand Medical Tourism Pricing & Economics Deep Dive

BCH listed Thai hospital operator with medical tourism, cross-border patient flows.

Open report →

Sits alongside 7 other Atlas profiles

Thailand Hospital Group Consolidation Deep Dive

BCH World Medical, WMC listed mid-tier consolidator.

Open report →

Sits alongside 7 other Atlas profiles

Related Market profiles

competitor

Bangkok Dusit Medical Services

Thailand's largest listed hospital group — 50+ hospitals across six brand families; >THB 110B FY2024 revenue.

competitor

Chularat Hospital

Eastern Thailand, EEC industrial-estate hospital specialist — SSS, corporate-contract franchise; FY2024 revenue ~THB 7B.

Key statistics for this sector

FY2024~3-4M2024 medical-tourism visitsView stat →2026 Q160+JCI-accredited hospitalsView stat →FY2024~47MUniversal Coverage Scheme beneficiariesView stat →FY2024>THB 110BBDMS FY2024 revenueView stat →
Bangkok Chain Hospital - Market Atlas · Insight